In November 2018, bioMérieux acquired a majority shareholding in Suzhou Hokapi Biomedical Engineering Co., Ltd. (also known as “Suzhou Hybiome Biomedical Engineering Co., Ltd.”).

With this acquisition, HOKAPI has formed a strong team of professionals specialized in clinical laboratory instruments and in vitro diagnostic reagents to address healthcare needs.

We are Dedicaled to Human Health & Well-being.